These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19928766)

  • 1. Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.
    Epple R; Cow C; Xie Y; Azimioara M; Russo R; Wang X; Wityak J; Karanewsky DS; Tuntland T; Nguyêñ-Trân VT; Cuc Ngo C; Huang D; Saez E; Spalding T; Gerken A; Iskandar M; Seidel HM; Tian SS
    J Med Chem; 2010 Jan; 53(1):77-105. PubMed ID: 19928766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) delta-selective agonists.
    Kasuga J; Nakagome I; Aoyama A; Sako K; Ishizawa M; Ogura M; Makishima M; Hirono S; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2007 Aug; 15(15):5177-90. PubMed ID: 17532641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis.
    Yin Y; Russell RG; Dettin LE; Bai R; Wei ZL; Kozikowski AP; Kopelovich L; Glazer RI
    Cancer Res; 2005 May; 65(9):3950-7. PubMed ID: 15867396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARdelta agonists.
    Zhang R; Deangelis A; Wang A; Sieber-McMaster E; Li X; Russell R; Pelton P; Xu J; Zhu P; Zhou L; Demarest K; Murray WV; Kuo GH
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1101-4. PubMed ID: 19168353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
    Rudolph J; Chen L; Majumdar D; Bullock WH; Burns M; Claus T; Dela Cruz FE; Daly M; Ehrgott FJ; Johnson JS; Livingston JN; Schoenleber RW; Shapiro J; Yang L; Tsutsumi M; Ma X
    J Med Chem; 2007 Mar; 50(5):984-1000. PubMed ID: 17274610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
    Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
    Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
    ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of a novel series of alpha-substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor (PPAR) alpha/delta dual agonists for the treatment of metabolic syndrome.
    Kasuga J; Yamasaki D; Araya Y; Nakagawa A; Makishima M; Doi T; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2006 Dec; 14(24):8405-14. PubMed ID: 16996742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective peroxisome proliferator-activated receptor δ isosteric selenium agonists as potent anti-atherogenic agents in vivo.
    Chin J; Hong JY; Lee J; Hwang H; Ko H; Choi H; Hahn D; Ko J; Nam SJ; Tak J; Ham J; Kang H
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7239-42. PubMed ID: 21074432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation.
    Sakuma S; Endo T; Kanda T; Nakamura H; Yamasaki S; Yamakawa T
    Bioorg Med Chem Lett; 2011 Jan; 21(1):240-4. PubMed ID: 21112784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
    Asaki T; Aoki T; Hamamoto T; Sugiyama Y; Ohmachi S; Kuwabara K; Murakami K; Todo M
    Bioorg Med Chem; 2008 Jan; 16(2):981-94. PubMed ID: 17964792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of structurally constrained oxime-ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists.
    Makadia P; Shah SR; Pingali H; Zaware P; Patel D; Pola S; Thube B; Priyadarshini P; Suthar D; Shah M; Giri S; Trivedi C; Jain M; Patel P; Bahekar R
    Bioorg Med Chem; 2011 Jan; 19(2):771-82. PubMed ID: 21215640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.
    Filzen GF; Bratton L; Cheng XM; Erasga N; Geyer A; Lee C; Lu G; Pulaski J; Sorenson RJ; Unangst PC; Trivedi BK; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3630-5. PubMed ID: 17512197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.
    Mahindroo N; Huang CF; Peng YH; Wang CC; Liao CC; Lien TW; Chittimalla SK; Huang WJ; Chai CH; Prakash E; Chen CP; Hsu TA; Peng CH; Lu IL; Lee LH; Chang YW; Chen WC; Chou YC; Chen CT; Goparaju CM; Chen YS; Lan SJ; Yu MC; Chen X; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2005 Dec; 48(26):8194-208. PubMed ID: 16366601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor structural modifications convert a selective PPARalpha agonist into a potent, highly selective PPARdelta agonist.
    Weigand S; Bischoff H; Dittrich-Wengenroth E; Heckroth H; Lang D; Vaupel A; Woltering M
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4619-23. PubMed ID: 16115765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists. Part 2.
    Epple R; Azimioara M; Russo R; Xie Y; Wang X; Cow C; Wityak J; Karanewsky D; Bursulaya B; Kreusch A; Tuntland T; Gerken A; Iskandar M; Saez E; Martin Seidel H; Tian SS
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5488-92. PubMed ID: 16931011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist.
    Shearer BG; Wiethe RW; Ashe A; Billin AN; Way JM; Stanley TB; Wagner CD; Xu RX; Leesnitzer LM; Merrihew RV; Shearer TW; Jeune MR; Ulrich JC; Willson TM
    J Med Chem; 2010 Feb; 53(4):1857-61. PubMed ID: 20128594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists.
    Kasuga J; Makishima M; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2006 Feb; 16(3):554-8. PubMed ID: 16275077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists.
    Bratton LD; Filzen GF; Geyer A; Hoffman JK; Lu G; Pulaski J; Trivedi BK; Unangst PC; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3624-9. PubMed ID: 17498950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453).
    Li J; Kennedy LJ; Shi Y; Tao S; Ye XY; Chen SY; Wang Y; Hernández AS; Wang W; Devasthale PV; Chen S; Lai Z; Zhang H; Wu S; Smirk RA; Bolton SA; Ryono DE; Zhang H; Lim NK; Chen BC; Locke KT; O'Malley KM; Zhang L; Srivastava RA; Miao B; Meyers DS; Monshizadegan H; Search D; Grimm D; Zhang R; Harrity T; Kunselman LK; Cap M; Kadiyala P; Hosagrahara V; Zhang L; Xu C; Li YX; Muckelbauer JK; Chang C; An Y; Krystek SR; Blanar MA; Zahler R; Mukherjee R; Cheng PT; Tino JA
    J Med Chem; 2010 Apr; 53(7):2854-64. PubMed ID: 20218621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.